FindTrial
Sign In

Study of personalized orthokeratology based on the efficacy prediction model

Study of personalized orthokeratology based on the efficacy prediction model

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072872
Enrollment
Unknown
Registered
2023-06-27
Start date
2023-07-01
Completion date
Unknown
Last updated
2023-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myopia

Interventions

experimental group 1:wearing ICF ortho-k
experimental group 2:wearing reduced BOZD ortho-k
control group:wearing conventional ortho-k

Sponsors

The First Affiliated Hospital of Chengdu Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 15 Years

Inclusion criteria

Inclusion criteria: An experience of myopia control in last 3 months(e.g. atropine, ortho-k) No contraindications for ortho-k 8 to 15 years old(inclusive) Myopia:1.00–6.00 D Anisometropia: =1.50 D Astigmatism: =1.00 D BCVA and NVA (logMAR) equal to or better than 0.00

Exclusion criteria

Exclusion criteria: Ocular or systemic disease Contraindications for OK lens Poor compliance

Design outcomes

Primary

MeasureTime frame
axial length;spherical equivalent;uncorrected visual acuity;best corrected visual acuity;intraocular pressure;abberation;contrast sensitivity;peripheral refraction;choroidal thickness;—

Secondary

MeasureTime frame
average keratometry;subjective complaints;near visual acuity;pupil diameter;accommodative amplitude;accommodation facility;breakup time;—

Countries

China

Contacts

Public ContactTang Wenting

The First Affiliated Hospital of Chengdu Medical College

tangwenting1983@sina.com+86 135 5135 0942

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026